Details for 2015728222
Up to date per 01.04.2026
Actions
Details for 2015728222
Granted/Registered
European Patent
15.02.2017 A
23.10.2019 B1
11.04.2014
US
201461978335 P
A61K 31/33 20060101AFI20151023BHEP
Owner
CymaBay Therapeutics, Inc.7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
ROBERTS, Brian7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
WANG, Xueyan7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
CHOI, Yun-Jung7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
KARPF, David7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
MARTIN, Robert7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
MCWHERTER, Charles A.7575 Gateway Boulevard, Suite 110 Newark, CA 94560US
Information about Fees